|
TABLE-Trinity Biotech Q3 net up 43 pct -- 7:57 AM EDT DUBLIN, Oct 24 (Reuters) - Three months to Sept 30, 2000 (million dollars unless stated) Shr (cents) 4.54 vs 4.28 Net profit 1.74 vs 1.21 Oper profit 1.73 vs 1.40 Revenues 7.6 vs 6.6 EBITDA* 2.10 vs 1.76 *Earnings before interest, tax, depreciation and amortisation. NOTE - Full name of the Irish diagnostic products manufacturer is Trinity Biotech Plc . ((Dublin newsroom, +353 1 500 1550, fax 500 1551, dublin.newsroom@reuters.com)) |
|
| aus der Diskussion: | Trinity Biotech |
| Autor (Datum des Eintrages): | SaintVenant (24.10.00 14:49:36) |
| Beitrag: | 38 von 141 (ID:2164355) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |